Lates News

Koji Pharmaceutical announced on the Hong Kong Stock Exchange that the board of directors has approved a share buyback program starting from May 8, 2025, for a period of 150 Hong Kong trading days, in accordance with the share buyback authorization for 2024 and (if applicable) the share buyback authorization approved at the annual general meeting of shareholders to be held on May 22, 2025, to repurchase up to 1% of the total issued shares of the company on the open market.